← FDA DRUG APPROVALS

FDA ANDA · ANDA203347

MARAVIROC

Sponsor: HETERO LABS LTD III

APPLICATION
ANDA203347
TYPE
ANDA
ORIGINAL APPROVAL
2022-02-07
LATEST ACTION
2022-02-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MARAVIROCPrescription
MARAVIROC 300MG · TABLET · ORAL
MARAVIROCPrescription
MARAVIROC 150MG · TABLET · ORAL

Approval history

2022-02-07UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →